Biopsy study to learn about mesothelioma and related cancers
Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study collects tissue samples (biopsies) and health information to better understand malignant mesothelioma and certain related solid tumors that may produce a protein called mesothelin. It may help future research and treatments, and you can only join if your diagnosis is confirmed and it’s safe for you to have the tissue taken.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 2 years old and have malignant mesothelioma, or you are 18+ with certain related cancers that may make mesothelin
- Your cancer diagnosis is confirmed by pathology (lab tissue/cell testing)
- You are able and willing to sign informed consent (or have a legal guardian consent if applicable)
- It must be medically safe for you to have a biopsy (no major unstable heart or lung problems, for example)
- You are not currently pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment called CAR T cells that target a protein called mesothelin found on certain cancer cells. The CAR T cells are made from your own immune cells and may help shrink tumors that have not responded to other therapies.
This research study collects tissue samples from people having surgery for pleural mesothelioma (a rare lung cancer) or other lung diseases. The samples are used to better understand the disease and improve future treatments.
This study is looking at the immune system and genes in mesothelioma tumors. It aims to learn more about how the body reacts to the cancer, which may help in finding better treatments in the future.
This study collects tissue samples (from the lining around the lung) from adults with malignant pleural mesothelioma. Researchers will use these samples to check whether certain test markers can predict how the disease may behave, which could guide treatment decisions in the future.
This study looks at the genetic changes (molecular analysis) in certain cancers of the chest. It may help doctors learn more about what drives these cancers and how they might be diagnosed or treated in the future.
This study collects medical information from people with suspected or confirmed thoracic cancer. The goal is to learn more about these cancers and improve future care.
Hear when a new Thymoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.